ETF Components for GNOM - Global X Genomics & Biotechnology ETF


Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

Holdings

Symbol Grade Price % Change Allocation
NTRA A 0.43 8.20
CRSP F 0.19 5.16
MRNA A 1.67 4.90
RARE D 0.67 4.89
A D 1.17 4.74
BMRN D -1.10 4.02
SRPT B 1.37 3.99
ILMN D 1.50 3.77
QGEN D 1.39 3.76
TECH F 2.35 3.73
RCKT F -0.81 3.59
RNA B 2.31 3.41
ARWR F 0.69 3.41
ALNY F 0.75 3.31
BNTX F 0.77 3.30
BEAM F -0.79 3.30
NTLA F 3.60 3.21
MYGN F 0.83 2.99
TXG F 2.38 2.86
LEGN F 1.85 2.77
VCYT F -1.03 2.76
VRTX C -0.05 1.97
SANA C 2.53 1.66
GILD F 0.23 1.55
VIR F 8.26 1.46
RGNX F 1.37 1.38
EDIT F 1.53 0.92
CDNA F -0.13 0.87
FLGT F 0.05 0.78
ALLO F 0.35 0.76
PACB F 6.52 0.69
CRBU F -1.33 0.60
LYEL C -1.36 0.59
VERV F -0.96 0.59
TSVT F -0.82 0.46
QURE F 0.33 0.40
PSTX F 3.66 0.27
BLUE F 1.71 0.20

Recent News for Global X Genomics & Biotechnology ETF & its Holdings

Date Stock Title
Apr 26 TECH Strong Quarterly Earnings Fuel Market Optimism Despite Inflation Concerns, Slowing Economic Growth: This Week In The Market
Apr 26 TECH Tech Stocks Rebound As Magnificent 7 Roar On Strong Earnings, Energy Giants Tumble: What's Driving Markets Friday?
Apr 26 TECH Generative AI In Beauty? Estee Lauder Strengthens Pacts With Microsoft To Create AI Lab
Apr 26 VRTX Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Apr 26 TECH 'Meta Actually Has Major Profit Margins Unlike Tesla': Redditor Reacts To Stock Drop Following Q1 Earnings
Apr 26 TECH Nvidia, Meta Among Tech Stocks That Stand To Benefit From 'Lots Of Infrastructure Spending On AI,' Says Tesla Bull Ross Gerber
Apr 26 TECH Elon Musk Weighs In After X User Says 'Banning TikTok Sets A Precedent That Government Can Ban Any App...'
Apr 26 TECH Meta Platforms Bought Some Time With Long-Term AI Potential
Apr 26 TECH Google 'Copy Pasted What META Did Last Quarter,' Redditor On Q1 Earnings
Apr 26 BMRN BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
Apr 26 ALLO Allogene Therapeutics Awarded Grant from the California Institute for Regenerative Medicine to Advance Development of an Allogeneic CAR T in Renal Cell Carcinoma
Apr 26 VRTX The Zacks Analyst Blog Highlights Biogen, Bristol Myers Squibb, Incyte and Vertex Pharmaceuticals
Apr 26 GILD Q1 2024 Gilead Sciences Inc Earnings Call
Apr 26 GILD FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Apr 26 TECH 'AI Is Important...For The Way We Deter Wars,' Says Anduril Founder After Winning US Air Force Contract To Develop Autonomous Fighter Jets
Apr 26 TECH Tesla Cybertruck Races World War 2-Era Fighter Plane At Orlando Air Show — Did It Win?
Apr 26 TECH Jim Cramer Says 'There Are Hundreds Of Articles' About Apple Losing Top Spot In China: 'Google And Microsoft Can Barely Buy An Inch Of Ink After Some Spectacular Quarters'
Apr 26 TECH Microsoft's Azure Strength Could Rub Off On This Warren Buffett-Backed Stock And Another Big Cloud Player, Says Analyst
Apr 26 ARWR Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars
Apr 26 TECH BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Exchange Traded Fund ETF Index Fund Biotechnology Genomics
Back to the Main GNOM Page...